These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19631208)

  • 1. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha.
    Madonna R; Shelat H; Xue Q; Willerson JT; De Caterina R; Geng YJ
    Exp Cell Res; 2009 Oct; 315(17):2921-8. PubMed ID: 19631208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells.
    Pregi N; Wenker S; Vittori D; Leirós CP; Nesse A
    Exp Cell Res; 2009 Feb; 315(3):419-31. PubMed ID: 19056379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release.
    Kin H; Wang NP; Mykytenko J; Reeves J; Deneve J; Jiang R; Zatta AJ; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Shock; 2008 Jun; 29(6):761-8. PubMed ID: 18496137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.
    Kewalramani G; Puthanveetil P; Wang F; Kim MS; Deppe S; Abrahani A; Luciani DS; Johnson JD; Rodrigues B
    Cardiovasc Res; 2009 Oct; 84(1):42-53. PubMed ID: 19477967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin does not attenuate cytokine production and inflammation in microglia--implications for the neuroprotective effect of erythropoietin in neurological diseases.
    Wilms H; Schwabedissen B; Sievers J; Lucius R
    J Neuroimmunol; 2009 Jul; 212(1-2):106-11. PubMed ID: 19464738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts.
    Ling S; Luo R; Dai A; Guo Z; Guo R; Komesaroff PA
    Phytomedicine; 2009 Jan; 16(1):56-64. PubMed ID: 19010649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.
    Madonna R; Geng YJ; Bolli R; Rokosh G; Ferdinandy P; Patterson C; De Caterina R
    J Biol Chem; 2014 Jul; 289(28):19585-98. PubMed ID: 24855642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection.
    Bogoyevitch MA
    Cardiovasc Res; 2004 Aug; 63(2):208-16. PubMed ID: 15249178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
    Wu H; Dong G; Liu H; Xu B; Li D; Jing H
    Eur J Pharmacol; 2009 Jan; 602(2-3):406-12. PubMed ID: 19061883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin reduces lipopolysaccharide-induced cell Damage and midkine secretion in U937 human histiocytic lymphoma cells.
    Yazihan N; Karakurt O; Ataoglu H
    Adv Ther; 2008 May; 25(5):502-14. PubMed ID: 18465096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin.
    van Tuyn J; Knaän-Shanzer S; van de Watering MJ; de Graaf M; van der Laarse A; Schalij MJ; van der Wall EE; de Vries AA; Atsma DE
    Cardiovasc Res; 2005 Aug; 67(2):245-55. PubMed ID: 15907818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
    Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Khai NC; Maruyama R; Ogino A; Minatoguchi S; Fujiwara T; Fujiwara H
    Circulation; 2006 Jan; 113(4):535-43. PubMed ID: 16449733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha inhibition of skeletal muscle regeneration is mediated by a caspase-dependent stem cell response.
    Moresi V; Pristerà A; Scicchitano BM; Molinaro M; Teodori L; Sassoon D; Adamo S; Coletti D
    Stem Cells; 2008 Apr; 26(4):997-1008. PubMed ID: 18258721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.
    Burger DE; Xiang FL; Hammoud L; Jones DL; Feng Q
    J Pharmacol Exp Ther; 2009 Jun; 329(3):900-7. PubMed ID: 19307451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants.
    Mir M; Asensio VJ; Tolosa L; Gou-Fabregas M; Soler RM; Lladó J; Olmos G
    Neuroscience; 2009 Sep; 162(4):959-71. PubMed ID: 19477238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?
    Chanséaume S; Azarnoush K; Maurel A; Bellamy V; Peyrard S; Bruneval P; Hagège AA; Menasché P
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):293-7. PubMed ID: 17669846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis in cardiac myocytes during the early stage after severe burn.
    Zhang JP; Ying X; Liang WY; Luo ZH; Yang ZC; Huang YS; Wang WC
    J Trauma; 2008 Aug; 65(2):401-8; discussion 408. PubMed ID: 18695479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma EPO and MIP-1 alpha are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts.
    Labonté L; Li Y; Yang L; Gillingham A; Halpenny M; Giulivi A; Sills T; Evans K; Zanke B; Allan DS
    Exp Hematol; 2009 Jun; 37(6):673-8. PubMed ID: 19463769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin protects critically perfused flap tissue.
    Rezaeian F; Wettstein R; Amon M; Scheuer C; Schramm R; Menger MD; Pittet B; Harder Y
    Ann Surg; 2008 Dec; 248(6):919-29. PubMed ID: 19092336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.